semaglutide
Compare Tirzepatide vs Semaglutide: 30% Fewer Deaths
A 3-year database shows Tirzepatide results in 30% fewer all-cause deaths than Semaglutide, raising questions about a shift in prescribing routine. The analysis covered over 120,000 Medicare beneficiaries and controlled for age, BMI, and comorbidities, providing a robust real-world perspective. Medical Disclaimer: This article is for informational purposes only